1-15 of 15
Balveen Kaur
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

NOTCH-Induced MDSC Recruitment after oHSV Virotherapy in CNS Cancer Models Modulates Antitumor Immunotherapy

Yoshihiro Otani, Ji Young Yoo, Cole T. Lewis, Samantha Chao, Jessica Swanner, Toshihiko Shimizu, Jin Muk Kang, Sara A. Murphy, Kimberly Rivera-Caraballo, Bangxing Hong, Joseph C. Glorioso, Hiroshi Nakashima, Sean E. Lawler, Yeshavanth Banasavadi-Siddegowda, John D. Heiss, Yuanqing Yan, Guangsheng Pei, Michael A. Caligiuri, Zhongming Zhao, E. Antonio Chiocca, Jianhua Yu, Balveen Kaur
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (7): 1460–1473.
https://doi.org/10.1158/1078-0432.CCR-21-2347
Published: 01 April 2022
View article titled, NOTCH-Induced MDSC Recruitment after oHSV Virotherapy in CNS Cancer Models Modulates Antitumor Immunotherapy
Open the PDF for NOTCH-Induced MDSC Recruitment after oHSV Virotherapy in CNS Cancer Models Modulates Antitumor Immunotherapy in another window
Includes: Supplementary data
Journal Articles

Targeting Fc Receptor-Mediated Effects and the “Don't Eat Me” Signal with an Oncolytic Virus Expressing an Anti-CD47 Antibody to Treat Metastatic Ovarian Cancer

Lei Tian, Bo Xu, Kun-Yu Teng, Mihae Song, Zheng Zhu, Yuqing Chen, Jing Wang, Jianying Zhang, Mingye Feng, Balveen Kaur, Lorna Rodriguez, Michael A. Caligiuri, Jianhua Yu
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (1): 201–214.
https://doi.org/10.1158/1078-0432.CCR-21-1248
Published: 05 January 2022
View article titled, Targeting Fc Receptor-Mediated Effects and the “Don't Eat Me” Signal with an Oncolytic Virus Expressing an Anti-CD47 Antibody to Treat Metastatic Ovarian Cancer
Open the PDF for Targeting Fc Receptor-Mediated Effects and the “Don't Eat Me” Signal with an Oncolytic Virus Expressing an Anti-CD47 Antibody to Treat Metastatic Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Oncolytic HSV Therapy Modulates Vesicular Trafficking Inducing Cisplatin Sensitivity and Antitumor Immunity

Bangxing Hong, Valerie Chapa, Uksha Saini, Puneet Modgil, David E. Cohn, Guangan He, Zahid H. Siddik, Anil K. Sood, Yuanqing Yan, Karuppaiyah Selvendiran, Guangsheng Pei, Zhongming Zhao, Ji Young Yoo, Balveen Kaur
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (2): 542–553.
https://doi.org/10.1158/1078-0432.CCR-20-2210
Published: 19 January 2021
View article titled, Oncolytic HSV Therapy Modulates Vesicular Trafficking Inducing Cisplatin Sensitivity and Antitumor Immunity
Open the PDF for Oncolytic HSV Therapy Modulates Vesicular Trafficking Inducing Cisplatin Sensitivity and Antitumor Immunity in another window
Includes: Supplementary data
Journal Articles

Oncolytic HSV–Infected Glioma Cells Activate NOTCH in Adjacent Tumor Cells Sensitizing Tumors to Gamma Secretase Inhibition

Yoshihiro Otani, Ji Young Yoo, Samantha Chao, Joseph Liu, Alena Cristina Jaime-Ramirez, Tae Jin Lee, Brian Hurwitz, Yuanqing Yan, Hongsheng Dai, Joseph C. Glorioso, Michael A. Caligiuri, Jianhua Yu, Balveen Kaur
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (10): 2381–2392.
https://doi.org/10.1158/1078-0432.CCR-19-3420
Published: 15 May 2020
View article titled, Oncolytic HSV–Infected Glioma Cells Activate NOTCH in Adjacent Tumor Cells Sensitizing Tumors to Gamma Secretase Inhibition
Open the PDF for Oncolytic HSV–Infected Glioma Cells Activate NOTCH in Adjacent Tumor Cells Sensitizing Tumors to Gamma Secretase Inhibition in another window
Includes: Supplementary data
Journal Articles

Efficacy of Onalespib, a Long-Acting Second-Generation HSP90 Inhibitor, as a Single Agent and in Combination with Temozolomide against Malignant Gliomas

Alessandro Canella, Alessandra M. Welker, Ji Young Yoo, Jihong Xu, Fazly S. Abas, Divya Kesanakurti, Prabakaran Nagarajan, Christine E. Beattie, Erik P. Sulman, Joseph Liu, Joy Gumin, Frederick F. Lang, Metin N. Gurcan, Balveen Kaur, Deepa Sampath, Vinay K. Puduvalli
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (20): 6215–6226.
https://doi.org/10.1158/1078-0432.CCR-16-3151
Published: 12 October 2017
View article titled, Efficacy of Onalespib, a Long-Acting Second-Generation HSP90 Inhibitor, as a Single Agent and in Combination with Temozolomide against Malignant Gliomas
Open the PDF for Efficacy of Onalespib, a Long-Acting Second-Generation HSP90 Inhibitor, as a Single Agent and in Combination with Temozolomide against Malignant Gliomas in another window
Includes: Supplementary data
Journal Articles

BAI1 Orchestrates Macrophage Inflammatory Response to HSV Infection—Implications for Oncolytic Viral Therapy

Chelsea Bolyard, W. Hans Meisen, Yeshavanth Banasavadi-Siddegowda, Jayson Hardcastle, Ji Young Yoo, Eric S. Wohleb, Jeffrey Wojton, Jun-Ge Yu, Samuel Dubin, Maninder Khosla, Bo Xu, Jonathan Smith, Christopher Alvarez-Breckenridge, Pete Pow-anpongkul, Flavia Pichiorri, Jianying Zhang, Matthew Old, Dan Zhu, Erwin G. Van Meir, Jonathan P. Godbout, Michael A. Caligiuri, Jianhua Yu, Balveen Kaur
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (7): 1809–1819.
https://doi.org/10.1158/1078-0432.CCR-16-1818
Published: 02 April 2017
View article titled, BAI1 Orchestrates Macrophage Inflammatory Response to HSV Infection—Implications for Oncolytic Viral Therapy
Open the PDF for BAI1 Orchestrates Macrophage Inflammatory Response to HSV Infection—Implications for Oncolytic Viral Therapy in another window
Includes: Supplementary data
Journal Articles

Bortezomib Treatment Sensitizes Oncolytic HSV-1–Treated Tumors to NK Cell Immunotherapy

Ji Young Yoo, Alena Cristina Jaime-Ramirez, Chelsea Bolyard, Hongsheng Dai, Tejaswini Nallanagulagari, Jeffrey Wojton, Brian S. Hurwitz, Theresa Relation, Tae Jin Lee, Michael T. Lotze, Jun-Ge Yu, Jianying Zhang, Carlo M. Croce, Jianhua Yu, Michael A. Caligiuri, Matthew Old, Balveen Kaur
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (21): 5265–5276.
https://doi.org/10.1158/1078-0432.CCR-16-1003
Published: 31 October 2016
View article titled, Bortezomib Treatment Sensitizes Oncolytic HSV-1–Treated Tumors to NK Cell Immunotherapy
Open the PDF for Bortezomib Treatment Sensitizes Oncolytic HSV-1–Treated Tumors to NK Cell Immunotherapy in another window
Includes: Supplementary data
Journal Articles

Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1–Mediated Lipogenesis

Feng Geng, Xiang Cheng, Xiaoning Wu, Ji Young Yoo, Chunming Cheng, Jeffrey Yunhua Guo, Xiaokui Mo, Peng Ru, Brian Hurwitz, Sung-Hak Kim, Jose Otero, Vinay Puduvalli, Etienne Lefai, Jianjie Ma, Ichiro Nakano, Craig Horbinski, Balveen Kaur, Arnab Chakravarti, Deliang Guo
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (21): 5337–5348.
https://doi.org/10.1158/1078-0432.CCR-15-2973
Published: 31 October 2016
View article titled, Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1–Mediated Lipogenesis
Open the PDF for Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1–Mediated Lipogenesis in another window
Includes: Supplementary data
Journal Articles

The Impact of Macrophage- and Microglia-Secreted TNFα on Oncolytic HSV-1 Therapy in the Glioblastoma Tumor Microenvironment

W. Hans Meisen, Eric S. Wohleb, Alena Cristina Jaime-Ramirez, Chelsea Bolyard, Ji Young Yoo, Luke Russell, Jayson Hardcastle, Samuel Dubin, Kamaldeen Muili, Jianhua Yu, Michael Caligiuri, Jonathan Godbout, Balveen Kaur
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (14): 3274–3285.
https://doi.org/10.1158/1078-0432.CCR-14-3118
Published: 14 July 2015
View article titled, The Impact of Macrophage- and Microglia-Secreted TNFα on Oncolytic HSV-1 Therapy in the Glioblastoma Tumor Microenvironment
Open the PDF for The Impact of Macrophage- and Microglia-Secreted TNFα on Oncolytic HSV-1 Therapy in the Glioblastoma Tumor Microenvironment in another window
Includes: Supplementary data
Journal Articles

Doxorubicin Synergizes with 34.5ENVE to Enhance Antitumor Efficacy against Metastatic Ovarian Cancer

Chelsea Bolyard, Ji Young Yoo, Pin-Yi Wang, Uksha Saini, Kellie S. Rath, Timothy P. Cripe, Jianying Zhang, Karuppaiyah Selvendiran, Balveen Kaur
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (24): 6479–6494.
https://doi.org/10.1158/1078-0432.CCR-14-0463
Published: 14 December 2014
View article titled, Doxorubicin Synergizes with 34.5ENVE to Enhance Antitumor Efficacy against Metastatic Ovarian Cancer
Open the PDF for Doxorubicin Synergizes with 34.5ENVE to Enhance Antitumor Efficacy against Metastatic Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Bortezomib-Induced Unfolded Protein Response Increases Oncolytic HSV-1 Replication Resulting in Synergistic Antitumor Effects

Ji Young Yoo, Brian S. Hurwitz, Chelsea Bolyard, Jun-Ge Yu, Jianying Zhang, Karuppaiyah Selvendiran, Kellie S. Rath, Shun He, Zachary Bailey, David Eaves, Timothy P. Cripe, Deborah S. Parris, Michael A. Caligiuri, Jianhua Yu, Matthew Old, Balveen Kaur
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (14): 3787–3798.
https://doi.org/10.1158/1078-0432.CCR-14-0553
Published: 14 July 2014
View article titled, Bortezomib-Induced Unfolded Protein Response Increases Oncolytic HSV-1 Replication Resulting in Synergistic Antitumor Effects
Open the PDF for Bortezomib-Induced Unfolded Protein Response Increases Oncolytic HSV-1 Replication Resulting in Synergistic Antitumor Effects in another window
Includes: Supplementary data
Journal Articles

DNA Demethylating Agents Synergize with Oncolytic HSV1 against Malignant Gliomas

Kazuo Okemoto, Kazue Kasai, Benjamin Wagner, Amy Haseley, Hans Meisen, Chelsea Bolyard, Xiaokui Mo, Allison Wehr, Amy Lehman, Soledad Fernandez, Balveen Kaur, E. Antonio Chiocca
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (21): 5952–5959.
https://doi.org/10.1158/1078-0432.CCR-12-3588
Published: 31 October 2013
View article titled, DNA Demethylating Agents Synergize with Oncolytic HSV1 against Malignant Gliomas
Open the PDF for DNA Demethylating Agents Synergize with Oncolytic HSV1 against Malignant Gliomas in another window
Includes: Supplementary data
Journal Articles

Copper Chelation Enhances Antitumor Efficacy and Systemic Delivery of Oncolytic HSV

Ji Young Yoo, Jason Pradarelli, Amy Haseley, Jeffrey Wojton, Azeem Kaka, Anna Bratasz, Christopher A. Alvarez-Breckenridge, Jun-Ge Yu, Kimerly Powell, Andrew P. Mazar, Theodoros N. Teknos, E. Antonio Chiocca, Joseph C. Glorioso, Matthew Old, Balveen Kaur
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (18): 4931–4941.
https://doi.org/10.1158/1078-0432.CCR-12-0697
Published: 16 September 2012
View article titled, Copper Chelation Enhances Antitumor Efficacy and Systemic Delivery of Oncolytic HSV
Open the PDF for Copper Chelation Enhances Antitumor Efficacy and Systemic Delivery of Oncolytic HSV in another window
Includes: Supplementary data
Journal Articles

Chondroitinase ABC I–Mediated Enhancement of Oncolytic Virus Spread and Antitumor Efficacy

Nina Dmitrieva, Lianbo Yu, Mariano Viapiano, Timothy P. Cripe, E. Antonio Chiocca, Joseph C. Glorioso, Balveen Kaur
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (6): 1362–1372.
https://doi.org/10.1158/1078-0432.CCR-10-2213
Published: 15 March 2011
View article titled, Chondroitinase ABC I–Mediated Enhancement of Oncolytic Virus Spread and Antitumor Efficacy
Open the PDF for Chondroitinase ABC I–Mediated Enhancement of Oncolytic Virus Spread and Antitumor Efficacy in another window
Includes: Supplementary data
Journal Articles

Cancer Therapy with a Replicating Oncolytic Adenovirus Targeting the Hypoxic Microenvironment of Tumors

Dawn E. Post, Narra Sarojini Devi, Zhenchao Li, Daniel J. Brat, Balveen Kaur, Ainsley Nicholson, Jeffrey J. Olson, Zhaobin Zhang, Erwin G. Van Meir
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (24): 8603–8612.
https://doi.org/10.1158/1078-0432.CCR-04-1432
Published: 28 December 2004
View article titled, Cancer Therapy with a Replicating Oncolytic Adenovirus Targeting the Hypoxic Microenvironment of Tumors
Open the PDF for Cancer Therapy with a Replicating Oncolytic Adenovirus Targeting the Hypoxic Microenvironment of Tumors in another window